Matches in Nanopublications for { ?s ?p "[TOP2A aberrations (amplification, deletion) are found in up to approximately 30-90 % of HER2 amplified breast cancer and amplifications are more common than deletions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_assertion description "[TOP2A aberrations (amplification, deletion) are found in up to approximately 30-90 % of HER2 amplified breast cancer and amplifications are more common than deletions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_provenance.
- NP732256.RAYyP__613Hrsu_segO6KgIEv_lc0M0rR0lnFotZZwZJ0130_assertion description "[TOP2A aberrations (amplification, deletion) are found in up to approximately 30-90 % of HER2 amplified breast cancer and amplifications are more common than deletions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732256.RAYyP__613Hrsu_segO6KgIEv_lc0M0rR0lnFotZZwZJ0130_provenance.
- NP732257.RAuFdJo1mkbVhePrqZeNRKZyGsSnPVa11QSAopjQuZC7E130_assertion description "[TOP2A aberrations (amplification, deletion) are found in up to approximately 30-90 % of HER2 amplified breast cancer and amplifications are more common than deletions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732257.RAuFdJo1mkbVhePrqZeNRKZyGsSnPVa11QSAopjQuZC7E130_provenance.